» Articles » PMID: 6287293

Corticotropin Releasing Activity of the New CRF is Potentiated Several Times by Vasopressin

Overview
Journal Nature
Specialty Science
Date 1982 Sep 23
PMID 6287293
Citations 146
Authors
Affiliations
Soon will be listed here.
Abstract

Initially the hypothalamic factor responsible for the release of corticotropin (CRF), was thought to be a simple peptide. More recent work has led to the conclusion that CRF is a multifactorial complex. In 1979 we proposed that vasopressin, much disputed as a CRF candidate, was a major constituent of the complex, interacting with a potentiating the CRF activity of the other component(s). The recent characterization of a 41 residue ovine hypothalamic peptide capable of releasing adrenocorticotropic hormone (ACTH) in a dose-related manner has allowed us to compare its CRF bioactivity with that of vasopressin and simple extracts of the hypothalamus, and to investigate any interaction it may have with vasopressin and other hypothalamic factors in the release of ACTH. We report here that the new CRF is more potent than vasopressin in releasing ACTH. When given simultaneously with vasopressin a fourfold potentiation of CRF activity with steep dose-response characteristics were observed. It also potentiated vasopressin-free hypothalamic extracts, suggesting that a new CRF does not account for all the nonvasopressin portion of the CRF complex.

Citing Articles

Roots and early routes of neuroendocrinology.

Rodriguez E, Guerra M, Blazquez J Cell Tissue Res. 2025; .

PMID: 39883141 DOI: 10.1007/s00441-024-03928-0.


Orally administered prednisolone decreases plasma arginine vasopressin and serum copeptin concentrations in healthy dogs.

Paulin M, Mehrabanpour D, Unniappan S, Snead E J Vet Intern Med. 2025; 39(1):e17304.

PMID: 39831546 PMC: 11744477. DOI: 10.1111/jvim.17304.


Molecular and functional mapping of the neuroendocrine hypothalamus: a new era begins.

Lee T, Nicolas J, Quarta C J Endocrinol Invest. 2024; 47(11):2627-2648.

PMID: 38878127 DOI: 10.1007/s40618-024-02411-5.


Androgen regulation of behavioral stress responses and the hypothalamic-pituitary-adrenal axis.

Zuloaga D, Lafrican J, Zuloaga K Horm Behav. 2024; 162:105528.

PMID: 38503191 PMC: 11144109. DOI: 10.1016/j.yhbeh.2024.105528.


New insights on diagnosis and treatment of AVP deficiency.

Refardt J, Atila C, Christ-Crain M Rev Endocr Metab Disord. 2023; 25(3):639-649.

PMID: 38087160 PMC: 11162367. DOI: 10.1007/s11154-023-09862-w.